ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
Shijin YuZongjun MaTao ChenHong WangQin YaoJin LiJie ChengPublished in: Oral diseases (2023)
Our findings reveal that ETV5 serves as a novel prognostic biomarker and putative oncogene for HNSCC progression likely by activating Slug transcription.